Restore Vision Inc.
PrivateLast Round
Series A
Dec 15, 2023
Total Funding Raised
$25.23M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Restore Vision Inc. is a Japanese biopharmaceutical company that develops gene therapies for patients with retinal disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Restore Vision Inc. Comparables
Compare Restore Vision Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nanoscope Therapeutics Inc. | 86% | |
| Ray Therapeutics | 81% | |
| Bionic Sight, Inc. | 80% |
Restore Vision Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 15, 2023 | ||||
| Series A | Jun 5, 2023 | ||||
| Seed | Feb 4, 2022 |
Key People
Founding team and executive leadership
Restore Vision Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Higin Capital | Series A |
| Remiges Ventures | Series A, Seed |
| ANRI株式会社 | Series A, Seed |
| QB Capital | Series A |
| Spiral Capital | Series A |
| Kyoto University Innovation Capital | Series A |
| Japan Science and Technology Agency | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 57% MoM.
- Apr 28, 2026
Grew 43% QoQ from 7 to 10 employees.
Restore Vision Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Restore Vision Inc.'s valuation, stock price, and market status.
Is Restore Vision Inc. a public or private company?
Restore Vision Inc. is a private company.
What is the current stock price of Restore Vision Inc.?
Restore Vision Inc. is a private company, so its shares have no public market price. Caplight tracks Restore Vision Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Restore Vision Inc. worth (valuation)?
Valuation information for Restore Vision Inc. is not publicly available.
Can I buy Restore Vision Inc. stock?
Restore Vision Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Restore Vision Inc.'s last funding round?
Restore Vision Inc.'s most recent funding round was Series A on December 15, 2023.
Who are the main investors in Restore Vision Inc.?
Key investors in Restore Vision Inc. include Remiges Ventures, ANRI株式会社, UntroD Capital Japan Inc..
Will Restore Vision Inc. IPO soon?
No public IPO plans have been announced for Restore Vision Inc..
How can I track Restore Vision Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Restore Vision Inc.'s shares on secondary markets.